367 related articles for article (PubMed ID: 33672186)
1. Ameliorating Fibrotic Phenotypes of Keloid Dermal Fibroblasts through an Epidermal Growth Factor-Mediated Extracellular Matrix Remodeling.
Kim H; Anggradita LD; Lee SJ; Hur SS; Bae J; Hwang NS; Nam SM; Hwang Y
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672186
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
3. Interplay Between Keratinocytes and Fibroblasts: A Systematic Review Providing a New Angle for Understanding Skin Fibrotic Disorders.
Russo B; Brembilla NC; Chizzolini C
Front Immunol; 2020; 11():648. PubMed ID: 32477322
[No Abstract] [Full Text] [Related]
4. Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction.
Marty P; Chatelain B; Lihoreau T; Tissot M; Dirand Z; Humbert P; Senez C; Secomandi E; Isidoro C; Rolin G
Biomed Pharmacother; 2021 Mar; 135():111182. PubMed ID: 33433355
[TBL] [Abstract][Full Text] [Related]
5. IFN-gamma fails to antagonize fibrotic effect of TGF-beta on keloid-derived dermal fibroblasts.
Hasegawa T; Nakao A; Sumiyoshi K; Tsuboi R; Ogawa H
J Dermatol Sci; 2003 Jun; 32(1):19-24. PubMed ID: 12788525
[TBL] [Abstract][Full Text] [Related]
6. Characterization of In Vitro Reconstructed Human Normotrophic, Hypertrophic, and Keloid Scar Models.
Limandjaja GC; van den Broek LJ; Breetveld M; Waaijman T; Monstrey S; de Boer EM; Scheper RJ; Niessen FB; Gibbs S
Tissue Eng Part C Methods; 2018 Apr; 24(4):242-253. PubMed ID: 29490604
[TBL] [Abstract][Full Text] [Related]
7. Co-localization of LTBP-2 with FGF-2 in fibrotic human keloid and hypertrophic scar.
Sideek MA; Teia A; Kopecki Z; Cowin AJ; Gibson MA
J Mol Histol; 2016 Feb; 47(1):35-45. PubMed ID: 26644005
[TBL] [Abstract][Full Text] [Related]
8. Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression.
Liu L; Yu H; Long Y; You Z; Ogawa R; Du Y; Huang C
FASEB J; 2021 Jul; 35(7):e21705. PubMed ID: 34105826
[TBL] [Abstract][Full Text] [Related]
9. Regulation of fibrotic changes by the synergistic effects of cytokines, dimensionality and matrix: Towards the development of an in vitro human dermal hypertrophic scar model.
Chawla S; Ghosh S
Acta Biomater; 2018 Mar; 69():131-145. PubMed ID: 29330036
[TBL] [Abstract][Full Text] [Related]
10. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
[TBL] [Abstract][Full Text] [Related]
11. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast of keloids and hypertrophic scars.
Bock O; Yu H; Zitron S; Bayat A; Ferguson MW; Mrowietz U
Acta Derm Venereol; 2005; 85(3):216-20. PubMed ID: 16040405
[TBL] [Abstract][Full Text] [Related]
12. The effect of the anti-allergic agent avil on abnormal scar fibroblasts.
Venugopal J; Ramakrishnan M; Habibullah CM; Babu M
Burns; 1999 May; 25(3):223-8. PubMed ID: 10323606
[TBL] [Abstract][Full Text] [Related]
13. Autocrine IL-6 drives cell and extracellular matrix anisotropy in scar fibroblasts.
Kenny FN; Marcotti S; De Freitas DB; Drudi EM; Leech V; Bell RE; Easton J; Díaz-de-la-Loza MD; Fleck R; Allison L; Philippeos C; Manhart A; Shaw TJ; Stramer BM
Matrix Biol; 2023 Nov; 123():1-16. PubMed ID: 37660739
[TBL] [Abstract][Full Text] [Related]
14. Adipose tissue-derived stromal cells inhibit TGF-β1-induced differentiation of human dermal fibroblasts and keloid scar-derived fibroblasts in a paracrine fashion.
Spiekman M; Przybyt E; Plantinga JA; Gibbs S; van der Lei B; Harmsen MC
Plast Reconstr Surg; 2014 Oct; 134(4):699-712. PubMed ID: 25357030
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis - Keloids and hypertrophic scars may be vascular disorders.
Ogawa R; Akaishi S
Med Hypotheses; 2016 Nov; 96():51-60. PubMed ID: 27959277
[TBL] [Abstract][Full Text] [Related]
16. Reconstructed human keloid models show heterogeneity within keloid scars.
Limandjaja GC; van den Broek LJ; Waaijman T; Breetveld M; Monstrey S; Scheper RJ; Niessen FB; Gibbs S
Arch Dermatol Res; 2018 Dec; 310(10):815-826. PubMed ID: 30370495
[TBL] [Abstract][Full Text] [Related]
17. Extracellular matrix molecules implicated in hypertrophic and keloid scarring.
Sidgwick GP; Bayat A
J Eur Acad Dermatol Venereol; 2012 Feb; 26(2):141-52. PubMed ID: 21838832
[TBL] [Abstract][Full Text] [Related]
18. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings.
Huang C; Akaishi S; Hyakusoku H; Ogawa R
Int Wound J; 2014 Oct; 11(5):517-22. PubMed ID: 23173565
[TBL] [Abstract][Full Text] [Related]
19. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids.
Lee WJ; Ahn HM; Roh H; Na Y; Choi IK; Lee JH; Kim YO; Lew DH; Yun CO
Exp Dermatol; 2015 Aug; 24(8):591-7. PubMed ID: 25865370
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin type A suppresses pro-fibrotic effects via the JNK signaling pathway in hypertrophic scar fibroblasts.
Park GS; An MK; Yoon JH; Park SS; Koh SH; Mauro TM; Cho EB; Park EJ; Kim KH; Kim KJ
Arch Dermatol Res; 2019 Dec; 311(10):807-814. PubMed ID: 31501922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
